TCG Crossover Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001839948

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2025 · 37 positions · Total reported value $875.51M · Top-10 concentration 56.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 45.9% · 12 new · 9 cut · 7 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +20.4% · vs SPY +5.6% · Prev Value $3.50B — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2025 13F filing, TCG Crossover Management, LLC disclosed 37 equity positions with a combined reported value of $875.51M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 56.3% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were CGON ($95.43M), TNGX ($54.97M), COGT ($50.00M). By sector, the heaviest allocations are Health Care 76.9%, Industrials 3.8%. Versus the prior quarter, allocation shifted toward Industrials (+1.2pp), Health Care (+1.1pp) and away from Other (-2.3pp).

Versus the prior quarter, TCG Crossover Management, LLC opened 12 new positions, trimmed 9 and fully exited 7, a turnover rate of 45.9% of positions. The portfolio's overlap with the prior quarter was 85% of names.

The largest new positions opened in Q2 2025 were AGIO ($23.18M), ELVN ($9.99M), JBIO ($639.59K).

Of the 7 positions fully exited versus the prior quarter, the largest were MLYS ($39.23M), CMPS ($11.03M), AVTE ($5.62M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • AGIO AGIOS PHARMACEUTICALS INC · $23.18M
  • ELVN ENLIVEN THERAPEUTICS INC · $9.99M
  • JBIO JADE BIOSCIENCES INC · $639.59K

Fully Exited (vs previous quarter)

  • MLYS Mineralys Therapeutics, Inc. · prev qtr: $39.23M
  • CMPS COMPASS PATHWAYS ADR A FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS · prev qtr: $11.03M
  • AVTE AEROVATE THERAPEUTICS INC · prev qtr: $5.62M

Insider Transactions (Form 4)

Latest TCG Crossover Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

TCG Crossover Management, LLC, based in Palo Alto, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 54 positions worth $4.16B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: PALO ALTO, CA, United States
  • SEC registration: 801-120001 (status: Approved), registered 2020-12-18
  • Regulatory AUM (Form ADV): $5.06B as of 2026-05-29
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds
  • Website: tcgcrossover.com

Portfolio Structure

  • 54 positions · $4.16B reported value (Q2 2026)
  • Top 10 holdings = 57.4% of reported value
  • Largest position: ABVX (ABIVAX SA) at 19.2%
  • Average position size: $77.05M

Sector Tilt

  • Health Care 99.3%
  • Financials 0.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 12 new, 2 added, 9 reduced, 7 exited
  • 31 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 76.9%
Other 19.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 3.67M $95.43M 10.90%
10.90%
Hold
2 10.74M $54.97M 6.28%
6.28%
Hold
3 6.96M $50.00M 5.71%
5.71%
Hold
4 5.32M $49.36M 5.64%
5.64%
Hold
5 1.01M $49.00M 5.60%
5.60%
Hold
6 6.06M $46.33M 5.29%
5.29%
Hold
7 5.94M $38.10M 4.35%
4.35%
Hold
8 2.89M $37.99M 4.34%
4.34%
Hold
9 5.25M $36.12M 4.13%
4.13%
Hold
10 3.77M $35.86M 4.10%
4.10%
Add
11 3.57M $33.62M 3.84%
3.84%
Hold
12 2.80M $30.76M 3.51%
3.51%
Hold
13 12.36M $28.19M 3.22%
3.22%
Hold
14 1.50M $27.98M 3.19%
3.19%
Hold
15 2.90M $27.73M 3.17%
3.17%
Hold
16 465.26K $24.64M 2.81%
2.81%
Hold
17 1.48M $23.63M 2.70%
2.70%
Hold
18 697.00K $23.18M 2.65%
2.65%
New
19 1.06M $22.05M 2.52%
2.52%
Hold
20 2.45M $19.27M 2.20%
2.20%
Hold
21 3.03M $17.59M 2.01%
2.01%
Hold
22 186.25K $15.60M 1.78%
1.78%
Reduce
23 2.76M $14.80M 1.69%
1.69%
Hold
24 1.64M $13.09M 1.50%
1.50%
Reduce
25 1.92M $10.40M 1.19%
1.19%
Reduce
26 498.00K $9.99M 1.14%
1.14%
New
27 650.00K $7.42M 0.85%
0.85%
Hold
28 266.67K $6.89M 0.79%
0.79%
Reduce
29 2.68M $5.35M 0.61%
0.61%
Hold
30 1.15M $4.27M 0.49%
0.49%
Hold
31 735.18K $4.24M 0.48%
0.48%
Reduce
32 584.96K $3.93M 0.45%
0.45%
Hold
33 1.80M $3.86M 0.44%
0.44%
Hold
34 483.00K $2.41M 0.28%
0.28%
Hold
35 316.19K $676.66K 0.08%
0.08%
Hold
36 64.02K $639.59K 0.07%
0.07%
New
37 86.80K $131.93K 0.01%
0.01%
Hold

FAQ

What did TCG Crossover Management, LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, TCG Crossover Management, LLC reported 37 equity positions worth $875.51M in aggregate; its largest disclosed positions were CGON ($95.43M), TNGX ($54.97M), COGT ($50.00M).

How large is TCG Crossover Management, LLC's portfolio?

TCG Crossover Management, LLC reported $875.51M of long equity holdings across 37 positions as of 2025-Q2. Top-10 holdings account for 56.3% of reported value.

What is TCG Crossover Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/tcg-crossover-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →